Inventor · disambiguated record
Jorge Mansilla-Soto
Also filed as: MANSILLA-SOTO JORGE · MANSILLA-SOTO JORGE A
7 granted patents·7 pending applications·13 citations·filing 2017–2025
79Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER14
Top patents by PatentIndex Score
14 records- 0191US11229669B2Cells comprising non-HLA restricted T cell receptorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Jan 25, 2022·3 cites·30 claims
- 0289US11932690B2Enhanced chimeric antigen receptors and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Mar 19, 2024·4 cites·40 claims
- 0386US11377637B2Transgenic T cell and chimeric antigen receptor T cell compositions and related methodsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 5, 2022·3 cites·7 claims
- 0484US11717579B2Globin gene therapy for treating hemoglobinopathiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Aug 8, 2023·3 cites·61 claims
- 0573US12404316B2Transgenic T cell and chimeric antigen receptor T cell compositions and related methodsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Sep 2, 2025·0 cites·15 claims
- 0670US12036244B2Cells comprising non-HLA restricted T cell receptorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jul 16, 2024·0 cites·21 claims
- 0769US2024166743A1Enhanced chimeric antigen receptors and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0866US2024066148A1Globin gene therapy for treating hemoglobinopathiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 0963US2023381315A1Cells with cd70 knockout and uses for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1062US12331129B2Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jun 17, 2025·0 cites·66 claims
- 1161US2020368283A1Non-hla restricted t cell receptors and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 1260US2025250356A1Chimeric receptors targeting adgre2 and/or clec12a and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 1357US2023346938A1Chimeric antigen receptors targeting cd19 and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1447US2025249101A1Cells and compositions for treating cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jorge Mansilla-Soto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →